Trial
NCT04128956
Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Zurich
Collaborators
University Hospital Heidelberg; Medical University of Vienna; RWTH Aachen University; Klinikum Arnsberg; University Hospital Freiburg
Condition
Venous Thromboses
Intervention
Aspirin 100mg
Why stopped
Recommendation by DSMB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-01